Flinton Capital Management’s Edwards Lifesciences EW Stock Holding History

Flinton Capital Management’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$3.13M	Buy	42,738 +5,610	+15%	+$394K	0.1%	170
2019 Q2	$2.29M	Buy	37,128 +5,610	+18%	+$339K	0.07%	206
2019 Q1	$2.01M	Buy	31,518 +4,080	+15%	+$233K	0.07%	214
2018 Q4	$1.4M	Buy	27,438 +2,856	+12%	+$145K	0.05%	234
2018 Q3	$1.43M	Sell	24,582 -306	-1%	-$15K	0.04%	259
2018 Q2	$1.21M	Buy	24,888 +1,428	+6%	+$66.7K	0.04%	281
2018 Q1	$1.09M	Sell	23,460 -2,040	-8%	-$88.6K	0.04%	273
2017 Q4	$958K	Buy	25,500 +5,916	+30%	+$217K	0.03%	293
2017 Q3	$714K	Sell	19,584 -10,506	-35%	-$401K	0.03%	324
2017 Q2	$1.19M	Sell	30,090 -16,014	-35%	-$585K	0.04%	249
2017 Q1	$1.45M	Sell	46,104 -93,126	-67%	-$2.92M	0.06%	221
2016 Q4	$4.35M	Buy	+139,230	New	+$4.51M	0.19%	104

Other funds holding EW

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Flinton Capital Management's EW Position: Q3 2019 in Review

Flinton Capital Management increased its Edwards Lifesciences (EW) stake by 15% in Q3 2019, buying an estimated $394K and bringing the position to 42,738 shares worth $3.13M. The position accounts for 0.1% of the portfolio, ranked #170.

Flinton Capital Management first reported a position in EW in Q4 2016 and has held it in 12 quarters since. The position peaked at $4.35M in Q4 2016. 964 funds tracked by Wall St. Rank hold EW as of Q3 2019.

Flinton Capital Management held 42,738 shares of Edwards Lifesciences worth $3.13M as of Q3 2019.
Flinton Capital Management bought 5,610 Edwards Lifesciences shares in Q3 2019, an estimated $394K.
Edwards Lifesciences made up 0.1% of Flinton Capital Management's portfolio in Q3 2019, its #170 holding.
Flinton Capital Management first reported a position in Edwards Lifesciences in Q4 2016 and has held it in 12 quarters since.
Flinton Capital Management's Edwards Lifesciences position peaked at $4.35M in Q4 2016.
964 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2019.

Based on Flinton Capital Management's 13F filing for Q3 2019, filed 14 Nov 2019.